Format
Sort by
Items per page

Send to

Choose Destination

Best matches for mania, acute AND manic state AND olanzapine AND valproic acid:

Search results

Items: 1 to 20 of 62

1.

Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis.

Lindström L, Lindström E, Nilsson M, Höistad M.

J Affect Disord. 2017 Apr 15;213:138-150. doi: 10.1016/j.jad.2017.02.012. Epub 2017 Feb 14. Review.

PMID:
28222360
2.
3.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Cipriani A, Reid K, Young AH, Macritchie K, Geddes J.

Cochrane Database Syst Rev. 2013 Oct 17;(10):CD003196. doi: 10.1002/14651858.CD003196.pub2. Review.

PMID:
24132760
4.

Korean medication algorithm for bipolar disorder: second revision.

Shin YC, Min KJ, Yoon BH, Kim W, Jon DI, Seo JS, Woo YS, Lee JG, Bahk WM.

Asia Pac Psychiatry. 2013 Dec;5(4):301-8. doi: 10.1111/appy.12062. Epub 2013 Apr 2.

PMID:
23857877
5.

Combination therapy for manic phases: a critical review of a common practice.

Geoffroy PA, Etain B, Henry C, Bellivier F.

CNS Neurosci Ther. 2012 Dec;18(12):957-64. doi: 10.1111/cns.12017. Epub 2012 Oct 25. Review.

6.

[Mood stabilizers in the treatment of bipolar disorder mixed states].

Rosso G, Bertetto N, Coppola I, Maina G.

Riv Psichiatr. 2012 Jul-Aug;47(4):281-93. doi: 10.1708/1139.12555. Review. Italian.

PMID:
23023078
7.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.

Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.

Curr Med Res Opin. 2012 May;28(5):701-13. doi: 10.1185/03007995.2012.666961. Epub 2012 Apr 10.

PMID:
22356118
8.

[Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences].

Salvi V, Cat Berro A, Bechon E, Bogetto F, Maina G.

Riv Psichiatr. 2011 May-Jun;46(3):172-81. doi: 10.1708/889.9807. Review. Italian.

PMID:
21779097
9.

Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.

Tarr GP, Glue P, Herbison P.

J Affect Disord. 2011 Nov;134(1-3):14-9. doi: 10.1016/j.jad.2010.11.009. Epub 2010 Dec 9. Review.

PMID:
21145595
10.

Efficacy of olanzapine and sodium valproate given alone or as add-on therapy in acute mania. A comparative study.

Kumar A, Gupta M, Jiloha RC, Tekur U.

Methods Find Exp Clin Pharmacol. 2010 Jun;32(5):319-24. doi: 10.1358/mf.2010.32.5.1440743.

PMID:
20664822
11.

Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.

Woodward TC, Tafesse E, Quon P, Lazarus A.

Pharmacoeconomics. 2010;28(9):751-64. doi: 10.2165/11538350-000000000-00000.

PMID:
20623994
12.

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S; WFSBP Task Force On Treatment Guidelines For Bipolar Disorders.

World J Biol Psychiatry. 2010 Mar;11(2):81-109. doi: 10.3109/15622970903555881.

PMID:
20148751
13.

Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.

Cipriani A, Rendell J, Geddes JR.

J Psychopharmacol. 2010 Dec;24(12):1729-38. doi: 10.1177/0269881109106900. Epub 2009 Oct 14. Review.

PMID:
19828571
14.

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.

Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.

J Clin Psychiatry. 2009 Nov;70(11):1540-7. doi: 10.4088/JCP.08m04895yel. Epub 2009 Sep 22. Erratum in: J Clin Psychiatry. 2011 Aug;72(8):1157. J Clin Psychiatry. 2010 Jan;71(1):93.

PMID:
19778495
15.

Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.

Fajutrao L, Paulsson B, Liu S, Locklear J.

Clin Ther. 2009 Jun;31 Pt 1:1456-68. doi: 10.1016/j.clinthera.2009.06.009.

PMID:
19698903
16.

Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.

Novick D, Gonzalez-Pinto A, Haro JM, Bertsch J, Reed C, Perrin E, Tohen M; EMBLEM Advisory Board.

Pharmacopsychiatry. 2009 Jul;42(4):145-52. doi: 10.1055/s-0028-1128115. Epub 2009 Jul 7.

PMID:
19585393
17.

A review of valproate in psychiatric practice.

Haddad PM, Das A, Ashfaq M, Wieck A.

Expert Opin Drug Metab Toxicol. 2009 May;5(5):539-51. doi: 10.1517/17425250902911455 . Review.

PMID:
19409030
18.

Olanzapine in long-term treatment for bipolar disorder.

Cipriani A, Rendell JM, Geddes J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004367. doi: 10.1002/14651858.CD004367.pub2. Review.

PMID:
19160237
19.

Revised Korean medication algorithm for bipolar disorder.

Jon DI, Bahk WM, Yoon BH, Shin YC, Cho HS, Lee E, Ha K, Kim W, Chung SK, Seo JS, Min KJ.

World J Biol Psychiatry. 2009;10(4 Pt 3):846-55. doi: 10.1080/15622970802144865.

PMID:
18615367
20.

Switching from other agents to extended-release carbamazepine in acute mania.

El-Mallakh RS, Ketter TA, Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Keck P, Swann AC, Kalali AH.

Psychopharmacol Bull. 2008;41(1):52-8.

PMID:
18362871

Supplemental Content

Loading ...
Support Center